Exploring GLP-1 Medications: Mental Health Benefits and Accessibility Challenges
Discover the mental health benefits of GLP-1 medications and the challenges of financial accessibility within Medicare coverage policies.
New Medicare GLP-1 Coverage Options Launching July 1
Starting July 1, Medicare Part D beneficiaries can access new GLP-1 drug coverage options, revolutionizing obesity treatment and policy enforcement.
Medicare's Coverage Expansion for Weight Loss Drugs: A Game Changer
Medicare expands coverage for GLP-1 weight loss drugs, improving access and driving economic changes. Learn how this initiative impacts healthcare access.
Medicare GLP-1 Bridge Program: Affordable Weight-Loss Medications for Seniors
Discover how the Medicare GLP-1 Bridge program offers affordable weight-loss medications for seniors, enhancing health outcomes and accessibility.
Medicare Announces GLP-1 Weight Loss Medication Pilot Program
Discover Medicare's new pilot program for weight loss medications, offering access to GLP-1 drugs for just $50/month, effective July 2026.
Impacts of Medicare Part D Changes on Insurers and Patients
Discover how recent Medicare Part D changes affect drug costs and access for seniors, influencing insurance strategies and patient financial planning.
Guide to Choosing Medicare Part D Plans in 2024
Learn how to choose the best Medicare Part D plan for 2024. Understand costs, coverage, and the valuable tools available for decision-making.
Coverage Initiative for GLP-1 Medications in Medicare
CMS initiates a temporary coverage program for GLP-1 medications aiming to assist Medicare beneficiaries before full BALANCE Model implementation. Learn more.
Medicare Part D Coverage Tightens as GLP-1 Drug Costs and Prior Authorizations Rise
Medicare Part D sees near-universal prior authorization and rising out-of-pocket costs for GLP-1 drugs in 2025, reflecting insurer adjustments to new cost and regulatory pressures.